Skip to content

Participate in our active studies Subscribe to our Mailing List

AB Science

Masitinib and AB8939 – Two compounds with breakthrough mechanism of action

Home
Company
Science
Pipeline
News and Media
Investors
Masivet®
- About Masivet®
- Medical information and Pharmacovigilance
Careers
Contact

Search:

Home
Company
Science
Pipeline
News and Media
Investors
Masivet®
- About Masivet®
- Medical information and Pharmacovigilance
Careers
Contact

Document de référence

You are here:

Home
Relations Investisseurs
Document de référence

Document de Référence

30/11/2016 – Document de Référence 2016

Post navigation

PreviousPrevious post:Foire Aux Questions NextNext post:AB8939

Related Posts

Rapports financiers annuels
May 2, 2018

Honoraires des Commissaires aux Comptes
May 2, 2018

Déclaration mensuelle du nombre total d’actions en circulation et des droits de vote
May 2, 2018

Documents relatifs aux Assemblées Générales
May 2, 2018

Autres informations
May 2, 2018

Calendrier Financier
May 2, 2018

AB SCIENCE
HEADQUARTER

3, Avenue George V – 75008 PARIS – FRANCE
Tel. : +33 (0)1 47 20 00 14
Fax. : +33 (0)1 47 20 24 11

GENERAL INQUIRIES

contact@ab-science.com

PRODUCT INQUIRIES

masivet@ab-science.com

JOB INQUIRIES

careers@ab-science.com

CLINICAL INQUIRIES

clinical@ab-science.com

MEDIA / FINANCIAL INQUIRIES

investors@ab-science.com

PHARMACOVIGILANCE

pharmacovigilance@ab-science.com
Fax : +33 1 47 20 10 82

© AB Science – All right reserved